Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: Findit who wrote (106746)	1/29/2004 7:17:56 PM
From: hotlinktuna	Respond to of 208838

Hi Jim! Good buy on SONS! I just got back and see I made up about 1/3 of what I lost yesterday, but that's still a sizeable hole! (NPCT and APT were both mean to me). Maybe this market can send us into the weekend with a gain tomorrow...hoping so anyway! I sold a lot of stuff again today with my moving sale...may cut it short tomorrow so I can actually see some of the market <gg> Best of luck to you and everyone tomorrow!! tuna

To: Findit who wrote (106746)	1/30/2004 8:29:27 AM
From: hotlinktuna	Respond to of 208838

Watch BIPH 1.13 on this news: Biophan Technologies to Present at FSX Capital Conference Friday January 30, 8:16 am ET CEO to Present at January 30th Dallas-based Broker/Dealer Conference ROCHESTER, N.Y.--(BUSINESS WIRE)--Jan. 30, 2004--Biophan Technologies, Inc. (OTC BB: BIPH), an innovator, developer, and marketer of advanced biomedical technology, announced today that Michael Weiner, Biophan's CEO, will be a speaker at the FSX Capital Conference in Dallas, Texas. The conference, also known as the Financial Services Exchange, commences today. The conference attendees are principally comprised of regional broker/dealers from across the United States, and emerging growth public companies. "Biophan makes a consistent effort to present our company at every opportunity to industry professionals," stated Mr. Weiner. "FSX is an excellent platform to discuss our Company and our commitment to growth." About Biophan Technologies Biophan Technologies develops and markets cutting-edge technologies used to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging (MRI) equipment. Committed to growth through innovation and developmental leadership, Biophan and its licensors have four issued U.S. patents and over fifty patents pending, in areas including nanomagnetic particle coatings, radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. Cautionary Statement This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risks that could cause actual performance and results of operations to differ materially from those anticipated by these statements. These risks and uncertainties include issues related to the ability to: obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new opportunities, and the unpredictable nature of business risks; as well as other factors set forth in the Company's most recently filed Form 10 reports. The forward-looking statements contained herein represent the Company's judgment as of the date of this release and it cautions readers not to place undue reliance on such statements. The Company assumes no obligation to update the statements contained in this release. Underwater on the first buy, but doubled up at 1.02 on a limit order yesterday...this may move the stock back up! tuna